Latest Articles
Endometrial cancer on the rise among young women - Free Malaysia Today
Endometrial cancer on the rise among young women Free Malaysia Today
Published: July 16, 2025, 12:30 a.m.
The Impact of Altered Gut Microbiota and Lipid Metabolism on the Progression of Endometrial Cancer in Overweight Populations - Frontiers
The Impact of Altered Gut Microbiota and Lipid Metabolism on the Progression of Endometrial Cancer in Overweight Populations Frontiers
Published: July 15, 2025, 8:06 p.m.
Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight - GlobeNewswire
Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight GlobeNewswire
Published: July 15, 2025, 5:01 p.m.
Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight - Yahoo Finance
Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight Yahoo Finance
Published: July 15, 2025, 5 p.m.
'I felt so weak': NC woman urges awareness after endometrial cancer diagnosis at 32 - WRAL.com
'I felt so weak': NC woman urges awareness after endometrial cancer diagnosis at 32 WRAL.com
Published: July 14, 2025, 5:53 p.m.
Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy - Labroots
Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy Labroots
Published: July 14, 2025, 10 a.m.
Kadriye Baskurt: Grateful to Have Joined the ESMO Endometrial Cancer Preceptorship in Lugano - Oncodaily
Kadriye Baskurt: Grateful to Have Joined the ESMO Endometrial Cancer Preceptorship in Lugano Oncodaily
Published: July 12, 2025, 8 p.m.
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer - OncLive
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer OncLive
Published: July 11, 2025, 6:17 p.m.
BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer TipRanks
Published: July 11, 2025, 4:24 p.m.
Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer - MSN
Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer MSN
Published: July 9, 2025, 11:31 p.m.
Link copied to clipboard!